141 related articles for article (PubMed ID: 8061281)
1. Neuroprotective effects of riluzole in ALS CSF toxicity.
Couratier P; Sindou P; Esclaire F; Louvel E; Hugon J
Neuroreport; 1994 Apr; 5(8):1012-4. PubMed ID: 8061281
[TBL] [Abstract][Full Text] [Related]
2. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors.
Couratier P; Hugon J; Sindou P; Vallat JM; Dumas M
Lancet; 1993 Jan; 341(8840):265-8. PubMed ID: 8093916
[TBL] [Abstract][Full Text] [Related]
3. Glutamate, excitotoxicity and amyotrophic lateral sclerosis.
Shaw PJ; Ince PG
J Neurol; 1997 May; 244 Suppl 2():S3-14. PubMed ID: 9178165
[TBL] [Abstract][Full Text] [Related]
4. Riluzole and ALS therapy.
Hugon J
Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
[TBL] [Abstract][Full Text] [Related]
5. The neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by riluzole.
Yáñez M; Matías-Guiu J; Arranz-Tagarro JA; Galán L; Viña D; Gómez-Pinedo U; Vela A; Guerrero A; Martínez-Vila E; García AG
Neurodegener Dis; 2014; 13(2-3):171-9. PubMed ID: 24356417
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
Sen I; Nalini A; Joshi NB; Joshi PG
J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
[TBL] [Abstract][Full Text] [Related]
7. CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole.
Yáñez M; Galán L; Matías-Guiu J; Vela A; Guerrero A; García AG
Brain Res; 2011 Nov; 1423():77-86. PubMed ID: 21983205
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro.
Anneser JM; Chahli C; Borasio GD
Neuroscience; 2006 Sep; 141(4):1879-86. PubMed ID: 16820266
[TBL] [Abstract][Full Text] [Related]
9. Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels.
Peña F; Tapia R
Neuroscience; 2000; 101(3):547-61. PubMed ID: 11113304
[TBL] [Abstract][Full Text] [Related]
10. Prevention of HIV coat protein (gp120) toxicity in cortical cell cultures by riluzole.
Sindou P; Couratier P; Esclaire F; Yardin C; Bousseau A; Hugon J
J Neurol Sci; 1994 Nov; 126(2):133-7. PubMed ID: 7853017
[TBL] [Abstract][Full Text] [Related]
11. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology and mechanism of action of riluzole.
Doble A
Neurology; 1996 Dec; 47(6 Suppl 4):S233-41. PubMed ID: 8959995
[TBL] [Abstract][Full Text] [Related]
13. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis.
Welty DF; Schielke GP; Rothstein JD
Ann Pharmacother; 1995 Nov; 29(11):1164-7. PubMed ID: 8573965
[TBL] [Abstract][Full Text] [Related]
14. Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block.
Cifra A; Nani F; Nistri A
Eur J Neurosci; 2011 Mar; 33(5):899-913. PubMed ID: 21324003
[TBL] [Abstract][Full Text] [Related]
15. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosis.
Iwasaki Y; Ikeda K; Kinoshita M
Curr Drug Targets CNS Neurol Disord; 2002 Oct; 1(5):511-8. PubMed ID: 12769603
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures.
Estevez AG; Stutzmann JM; Barbeito L
Eur J Pharmacol; 1995 Jun; 280(1):47-53. PubMed ID: 7498253
[TBL] [Abstract][Full Text] [Related]
18. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.
Rothstein JD
Adv Neurol; 1995; 68():7-20; discussion 21-7. PubMed ID: 8787245
[TBL] [Abstract][Full Text] [Related]
19. Low concentrations of glutamate induce apoptosis in cultured neurons: implications for amyotrophic lateral sclerosis.
Cid C; Alvarez-Cermeño JC; Regidor I; Salinas M; Alcazar A
J Neurol Sci; 2003 Jan; 206(1):91-5. PubMed ID: 12480091
[TBL] [Abstract][Full Text] [Related]
20. Riluzole for amyotrophic lateral sclerosis.
Drug Ther Bull; 1997 Feb; 35(2):11-2. PubMed ID: 9282413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
